Meeting 6

From 2012e.igem.org

(Difference between revisions)
 
(One intermediate revision not shown)
Line 19: Line 19:
<h3>Feedback Discussion</h3>
<h3>Feedback Discussion</h3>
<div align="justify">
<div align="justify">
-
After to receive the feedback from the HQ of iGEME, we discussed and concluded the following:<br>
+
After we received the feedback from the iGEME HQ, we discussed and concluded the following:<br>
<br>
<br>
-
The service that we offer depends on: the entity that developed the biological process and the companie who assembled the secuencies.<br>
+
The service that we offer depends on: the entity that developed the biological process and the company who assembled the sequencies.<br>
<br>
<br>
-
It is necessary to know that the company who supplies us with the sequence has a quality warranty in order that we can offer a quality product and service.<br>
+
It is necessary to know that the company who supplies us with the sequence has a quality warranty in order to offer a quality product and service.<br>
<br>
<br>
-
We will to take care about the returns and exchanges, this way our customers wouldn't have to worry about the transaction.<br>
+
We will take care of the returns and exchanges, this way our customers wouldn't have to worry about the transaction post purchase.<br>
<br>
<br>
-
We have to establish an association with the delivering companies to carry on the biologicals processes that we go to offer to our customers.<br>
+
We have to establish an association with the delivering companies to carry on the biologicals processes that will offer our customers.<br>
<br>
<br>
-
About the costs, it will depends on the development cost, secuence service cost, delivering cost, complexity of the secuence and our comission. We know that is not cheap but for that reason our segment customer is a niche market with especific needs.<br>
+
About the costs, it will depend on the development cost, sequence service cost, delivering cost, complexity of the sequence and our comission. We know that is not cheap, but for that reason our segment customer is a niche market with specific needs.<br>
<br>
<br>

Latest revision as of 12:00, 28 October 2012


IGEMe.png


Home

The Team

Executive Summary

Project Description

Business Model

Video

Slide Deck

Notebook

Sponsors




Team's Meetings
Meeting 1 Meeting 2 Meeting 3 Metting 4 Meeting 5 Meeting 6
Meeting 6


Feedback Discussion

After we received the feedback from the iGEME HQ, we discussed and concluded the following:

The service that we offer depends on: the entity that developed the biological process and the company who assembled the sequencies.

It is necessary to know that the company who supplies us with the sequence has a quality warranty in order to offer a quality product and service.

We will take care of the returns and exchanges, this way our customers wouldn't have to worry about the transaction post purchase.

We have to establish an association with the delivering companies to carry on the biologicals processes that will offer our customers.

About the costs, it will depend on the development cost, sequence service cost, delivering cost, complexity of the sequence and our comission. We know that is not cheap, but for that reason our segment customer is a niche market with specific needs.